YQHX Alleviates H/R-Induced Cardiomyocyte Apoptosis by Downregulating miR-1.

Luandie Ge, Yaqi Fan, Lin Fu, Mengjiao Guo, Panxia Cao, Chaojie Peng, Linke Wu, Lihua Han, Hong Wu
Author Information
  1. Luandie Ge: Graduate School, Henan University of Chinese Medicine, Zhengzhou 450046, China. ORCID
  2. Yaqi Fan: Graduate School, Henan University of Chinese Medicine, Zhengzhou 450046, China. ORCID
  3. Lin Fu: Graduate School, Henan University of Chinese Medicine, Zhengzhou 450046, China. ORCID
  4. Mengjiao Guo: Graduate School, Henan University of Chinese Medicine, Zhengzhou 450046, China. ORCID
  5. Panxia Cao: Graduate School, Henan University of Chinese Medicine, Zhengzhou 450046, China. ORCID
  6. Chaojie Peng: Graduate School, Henan University of Chinese Medicine, Zhengzhou 450046, China. ORCID
  7. Linke Wu: Graduate School, Henan University of Chinese Medicine, Zhengzhou 450046, China. ORCID
  8. Lihua Han: Institute of Cardiovascular Disease, Henan University of Chinese Medicine, Zhengzhou 450002, China. ORCID
  9. Hong Wu: Graduate School, Henan University of Chinese Medicine, Zhengzhou 450046, China. ORCID

Abstract

Yiqi Huoxue granule (YQHX) inhibits cardiomyocyte apoptosis in myocardial ischemia-reperfusion injury (MIRI); however, the underlying mechanism is unknown. In this study, hypoxia-reoxygenation (H/R) models were established using rat myocardial primary cells and H9c2 cells, lactate dehydrogenase (LDH), and creatine kinase (CK) levels and cardiomyocyte apoptosis were determined. LDH release, CK activity, caspase-3 activation, mRNA and protein ratio of Bax/Bcl-2, and miR-1 expression were significantly higher ( < 0.01) in the H/R model of rat myocardial primary cells and H9c2 cells compared with the control group and was inhibited by YQHX treatment ( < 0.01 or < 0.05). We also found that miR-1 overexpression could enhance apoptosis in cardiomyocytes, whereas apoptosis could be reduced by YQHX treatment ( < 0.01). In conclusion, YQHX alleviates H/R-induced cardiomyocyte apoptosis by inhibiting miR-1 expression, suggesting the potential of YQHX in preventing MIRI.

References

Exp Ther Med. 2016 Jun;11(6):2407-2412 [PMID: 27284328]
PLoS One. 2018 Jun 21;13(6):e0198272 [PMID: 29927947]
Mol Med Rep. 2019 May;19(5):3527-3536 [PMID: 30896796]
Exp Anim. 2019 Nov 6;68(4):549-558 [PMID: 31243190]
Front Pharmacol. 2020 Mar 27;11:367 [PMID: 32292345]
Inflammation. 2020 Apr;43(2):605-618 [PMID: 31900829]
Drug Des Devel Ther. 2019 May 01;13:1437-1447 [PMID: 31118578]
Life Sci. 2021 Jun 15;275:119414 [PMID: 33774032]
Am J Transl Res. 2015 Oct 15;7(10):1952-62 [PMID: 26692938]
J Cell Mol Med. 2018 Oct;22(10):4830-4839 [PMID: 30117672]
Evid Based Complement Alternat Med. 2020 May 18;2020:9786482 [PMID: 32508960]
Phytomedicine. 2019 Feb;53:171-181 [PMID: 30668396]
Int J Mol Sci. 2020 Jan 21;21(3): [PMID: 31973111]
J Geriatr Cardiol. 2020 Jan;17(1):1-8 [PMID: 32133031]
Mol Med Rep. 2019 Oct;20(4):3764-3772 [PMID: 31485622]
Ann Palliat Med. 2019 Nov;8(5):565-575 [PMID: 31865720]
Oxid Med Cell Longev. 2019 May 2;2019:6791457 [PMID: 31191802]
Evid Based Complement Alternat Med. 2015;2015:171306 [PMID: 26074986]
Int J Mol Med. 2019 Nov;44(5):1899-1907 [PMID: 31485642]

Word Cloud

Similar Articles

Cited By